Curaden

Management of type 1 diabetes patients in dentistry can be a challenge. Tailored dental care programme makes a difference. The main goal of the insulin-dependent diabetes care programme is to early classify the high-risk groups to improve general oral health and thus improve the quality of life of our patients.

Periodontal disease and diabetes share some life-style risk factors, like smoking, and there is a two-way relationship: patients with uncontrolled diabetes have a 3-fold higher risk to develop advanced periodontitis, while untreated periodontitis further dysregulates glycemic balance.

In patients with type 2 diabetes an inflammatory process is present. This inflammation is due to a pathological activation of the innate immune system, caused by metabolic stress and is partly governed by IL-1 signaling. We identified the role of IL-1β and insulin in the regulation of metabolism and immunity in response to food intake. Yet, as it becomes chronic, activation of auto-inflammatory processes may then become deleterious.

Despite all efforts of dental professionals the prevalence and incidence of total edentulism is still increasing on a global scale. Second observation from a recent meta review in JDR (2020) was that total tooth loss is decreasing in low-income countries while, on the other hand, it is increasing in upper- or middle-income countries. Is periodontal disease the main responsible for this evolution?

Dental professionals must frequently draw upon their knowledge of pharmacology for optimal care of today’s medically complex geriatric dental patients. However, armed with relatively brief exposure to such a vast subject during formal education and faced with ever-changing medication therapy guidelines, many dental professionals simply cannot keep up with the latest trends in disease state management.

Across the globe the population is ageing. Whilst increasing numbers of older people retain natural teeth, a sizable proportion of older people are still edentate. Replacement of missing teeth is important for function, aesthetics and to facilitate social inter-actions. This lecture will discuss treatment for edentate and partially dentate older adults including planning for removable and fixed prosthodontics.

Cancer treatment is by its very nature highly cytotoxic. In this way, cells and tissues are affected in different ways and patients may experience different reactions and adverse effects. The mouth is a site often affected in treatment and therefore the dentist should be involved in preventing and treating possible complications, before, during and after the end of cancer treatment.

400,000 to 500,000 new cases world wide of oral cancer are diagnosed and causes about 150,000 deaths per year. More than 60 percent of the patients are diagnosed with late stage (III or IV stage) disease, therefore, 5-year overall survival rate is as low as 50 percent. Stage I-II may have excellent cure rates with minor surgery and few functional sequelae, highlighting the necessity for early diagnosis and heightened awareness in dentists.

According to WHO, Cancer is the second leading cause of death globally, accounting for an estimated 9.6 million deaths, or one in six deaths, in 2018. Lung, prostate, colorectal, stomach and liver cancer are the most common types of cancer in men, while breast, colorectal, lung, cervical and thyroid cancer are the most common among women. Dental professionals play a significant role for their patients that are undergoing oncology treatment. We will discuss the challenges dental professionals face when confronted with oncology patients.

Digitalización de los tratamientos de ortodoncia debido al virus pandémico.